With SARS-CoV-II now an important player in the market, anyone with a net long portfolio should look into reducing their exposure to the virus. Qurate (QRTEA) is one stock for which articles rarely mention its Chinese exposure. The exposure comes in two flavors: product manufacturing and sales via its joint venture in China as well as QRTEA’s acquisition of Zulily, which sees its highest margins in China.
The former will be affected by China’s factory shutdowns. The latter will be affected by China’s economic downturn in light of consumers prioritizing masks and bare